Jeffrey L Weinstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology, Interventional | 5 | 2024 | 483 | 1.740 |
Why?
|
Catheterization, Central Venous | 2 | 2024 | 538 | 1.290 |
Why?
|
Vena Cava Filters | 4 | 2024 | 270 | 1.050 |
Why?
|
Hand | 4 | 2024 | 910 | 0.950 |
Why?
|
Clinical Competence | 5 | 2024 | 4858 | 0.930 |
Why?
|
Aneurysm, False | 2 | 2024 | 264 | 0.890 |
Why?
|
Radiography, Interventional | 6 | 2020 | 1129 | 0.890 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2024 | 291 | 0.810 |
Why?
|
Liver Transplantation | 5 | 2023 | 2416 | 0.780 |
Why?
|
Needles | 1 | 2024 | 461 | 0.730 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 159 | 0.670 |
Why?
|
Pulmonary Embolism | 6 | 2024 | 2596 | 0.670 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2023 | 95 | 0.660 |
Why?
|
Ultrasonography, Interventional | 5 | 2024 | 1521 | 0.640 |
Why?
|
Radial Artery | 1 | 2020 | 187 | 0.640 |
Why?
|
Motor Skills | 1 | 2020 | 519 | 0.570 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 346 | 0.560 |
Why?
|
Liver Neoplasms | 7 | 2024 | 4356 | 0.550 |
Why?
|
Benchmarking | 1 | 2023 | 1056 | 0.530 |
Why?
|
Renal Dialysis | 2 | 2024 | 1790 | 0.530 |
Why?
|
Phantoms, Imaging | 1 | 2024 | 2474 | 0.510 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2024 | 2329 | 0.490 |
Why?
|
Ablation Techniques | 1 | 2018 | 254 | 0.490 |
Why?
|
Thrombolytic Therapy | 5 | 2022 | 2053 | 0.470 |
Why?
|
Vascular Patency | 3 | 2024 | 915 | 0.370 |
Why?
|
Device Removal | 2 | 2024 | 643 | 0.320 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1403 | 0.320 |
Why?
|
Yttrium Radioisotopes | 3 | 2024 | 116 | 0.290 |
Why?
|
Catheters | 2 | 2022 | 428 | 0.290 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 538 | 0.280 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 2078 | 0.260 |
Why?
|
Microspheres | 3 | 2024 | 774 | 0.260 |
Why?
|
Physicians | 1 | 2023 | 4591 | 0.250 |
Why?
|
Venous Thrombosis | 3 | 2024 | 1321 | 0.250 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 614 | 0.230 |
Why?
|
Internship and Residency | 1 | 2023 | 5943 | 0.210 |
Why?
|
Patient Readmission | 5 | 2020 | 3283 | 0.200 |
Why?
|
Surgery, Computer-Assisted | 1 | 2010 | 996 | 0.200 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1506 | 0.200 |
Why?
|
Stents | 3 | 2023 | 3193 | 0.190 |
Why?
|
Thrombin | 1 | 2024 | 600 | 0.190 |
Why?
|
Varicose Veins | 1 | 2023 | 158 | 0.190 |
Why?
|
Esophageal and Gastric Varices | 1 | 2023 | 215 | 0.180 |
Why?
|
Splenic Artery | 1 | 2021 | 58 | 0.180 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 463 | 0.180 |
Why?
|
Task Performance and Analysis | 1 | 2024 | 771 | 0.170 |
Why?
|
Drug Costs | 1 | 2018 | 1194 | 0.170 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2024 | 463 | 0.170 |
Why?
|
Time Factors | 5 | 2024 | 40149 | 0.160 |
Why?
|
Pericardiectomy | 1 | 2019 | 45 | 0.160 |
Why?
|
Embolectomy | 1 | 2020 | 130 | 0.160 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 87 | 0.160 |
Why?
|
Punctures | 1 | 2020 | 371 | 0.160 |
Why?
|
Graft Survival | 2 | 2018 | 3904 | 0.160 |
Why?
|
Upper Extremity | 1 | 2024 | 684 | 0.160 |
Why?
|
Video Recording | 1 | 2024 | 977 | 0.160 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 179 | 0.160 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 73 | 0.150 |
Why?
|
Portal Vein | 2 | 2023 | 437 | 0.150 |
Why?
|
Empyema, Pleural | 1 | 2018 | 62 | 0.150 |
Why?
|
Medicare | 3 | 2024 | 6813 | 0.150 |
Why?
|
Humans | 37 | 2024 | 766812 | 0.140 |
Why?
|
Patient Care Team | 2 | 2020 | 2519 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1481 | 0.140 |
Why?
|
Hepatic Artery | 1 | 2018 | 233 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 2019 | 246 | 0.140 |
Why?
|
Treatment Outcome | 15 | 2024 | 65286 | 0.140 |
Why?
|
Thrombectomy | 2 | 2023 | 676 | 0.140 |
Why?
|
Drainage | 2 | 2019 | 1182 | 0.130 |
Why?
|
Foot Diseases | 1 | 2017 | 148 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 196 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 562 | 0.130 |
Why?
|
Hospital Mortality | 2 | 2020 | 5344 | 0.130 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2018 | 296 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4215 | 0.120 |
Why?
|
Graft Rejection | 1 | 2018 | 4504 | 0.120 |
Why?
|
Acute Disease | 2 | 2022 | 7240 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 592 | 0.120 |
Why?
|
Teaching Rounds | 1 | 2019 | 280 | 0.120 |
Why?
|
Retrospective Studies | 14 | 2024 | 81657 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 369 | 0.110 |
Why?
|
Angioplasty | 1 | 2016 | 355 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 641 | 0.110 |
Why?
|
Hepatectomy | 1 | 2016 | 589 | 0.100 |
Why?
|
Cryosurgery | 1 | 2017 | 479 | 0.100 |
Why?
|
Ultrasonography | 2 | 2023 | 5990 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2021 | 15831 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2024 | 2505 | 0.100 |
Why?
|
Hemorrhage | 2 | 2020 | 3464 | 0.090 |
Why?
|
Male | 22 | 2024 | 364154 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1359 | 0.090 |
Why?
|
Middle Aged | 19 | 2024 | 223267 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5306 | 0.080 |
Why?
|
Learning | 1 | 2019 | 1754 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1547 | 0.080 |
Why?
|
Female | 18 | 2024 | 396532 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3934 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1804 | 0.080 |
Why?
|
Pilot Projects | 1 | 2020 | 8728 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3618 | 0.070 |
Why?
|
Italy | 1 | 2018 | 856 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4853 | 0.070 |
Why?
|
Quality Improvement | 2 | 2018 | 3850 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8540 | 0.060 |
Why?
|
Mortality | 1 | 2017 | 2908 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3111 | 0.060 |
Why?
|
Consensus | 3 | 2019 | 3208 | 0.060 |
Why?
|
Aged | 12 | 2024 | 171344 | 0.060 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 810 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2023 | 1126 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3186 | 0.060 |
Why?
|
Liver | 2 | 2018 | 7571 | 0.060 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 641 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3614 | 0.050 |
Why?
|
Cost Savings | 1 | 2018 | 903 | 0.050 |
Why?
|
Brachial Artery | 1 | 2024 | 373 | 0.050 |
Why?
|
Systems Analysis | 1 | 2023 | 168 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4282 | 0.050 |
Why?
|
Hemostatics | 1 | 2024 | 247 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4854 | 0.050 |
Why?
|
Ascites | 1 | 2023 | 336 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3485 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 303 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7475 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 713 | 0.040 |
Why?
|
Cholangiography | 1 | 2019 | 182 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 158 | 0.040 |
Why?
|
Echocardiography | 2 | 2022 | 5038 | 0.040 |
Why?
|
Chest Tubes | 1 | 2018 | 153 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
Risk Factors | 5 | 2020 | 74889 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 331 | 0.030 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 128 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2023 | 2425 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54872 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6491 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 654 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5536 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 574 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1104 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1596 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1838 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1905 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 892 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13644 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 643 | 0.030 |
Why?
|
Hypertrophy | 1 | 2016 | 562 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 859 | 0.030 |
Why?
|
Adult | 6 | 2024 | 223305 | 0.030 |
Why?
|
Foot | 1 | 2017 | 576 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.030 |
Why?
|
Databases, Factual | 1 | 2018 | 8065 | 0.030 |
Why?
|
United States | 3 | 2024 | 72945 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18397 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2022 | 2779 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1750 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1960 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1065 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3384 | 0.020 |
Why?
|
Heart Arrest | 1 | 2019 | 1516 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3717 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59548 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2727 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4325 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3831 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5618 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8507 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5143 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3576 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3563 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4892 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39312 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21527 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9346 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13276 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4252 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12826 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29959 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41706 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20710 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36459 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24299 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42577 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59939 | 0.010 |
Why?
|